April 29th Basel Healthcare Dialogues Event

On Thursday, 29^th April, from 1:00 pm to 1:50 pm CET (Switzerland Time) 8:00 to 8:50 p.m. (China/HK/SG Time), Basel HCD welcomes Juergen Betzing, CEO, IDT Biologika (https://idt-biologika.com/). Jurgen will give a talk entitled "Can Europe Become Self-sufficient in Vaccine Production?".

The European Covid-19 vaccination drive continues to be hit by setbacks. There is a need to massively increase vaccination production capacities. At least 1.4 billion doses of the four coronavirus vaccines authorized in the EU have been ordered. Although this should be more than sufficient for some 450 million people in the EU, supply difficulties, export restrictions and bureaucratic tangles have led to a current shortfall in the bloc — which lags well behind the US, UK and Israel with its vaccination drive.
 
Does Europe have the political will and the financial resources, as well as the required know-how, to become self-sufficient in vaccine production? What is the scale of the investment required? Where are the major roadblocks? How well is Europe prepared for the next pandemic? To address these and other questions, join us in a no-holds barred meeting with Juergen Betzing, CEO of IDT Biologika.

Juergen Betzing CEO, IDT Biologika A down-to-earth hands-on entrepreneur, Juergen is ambitious, an excellent communicator and a results-driven senior executive. His past association has been with well-known European companies such as Acino Pharma, Mepha, Siegfried, EVOMED & Gruenenthal.